{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T08:58:03Z","timestamp":1791622683727,"version":"4.3.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T00:00:00Z","timestamp":1396224000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/2051-5960-2-35","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T15:08:13Z","timestamp":1396278493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":123,"title":["Neuromyelitis optica MOG-IgG causes reversible lesions in mouse brain"],"prefix":"10.1186","volume":"2","author":[{"given":"Samira","family":"Saadoun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Waters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory P","family":"Owens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Vincent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marios C","family":"Papadopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,31]]},"reference":[{"issue":"9","key":"107_CR1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1212\/WNL.0b013e318248dec1","volume":"78","author":"PJ Waters","year":"2012","unstructured":"Waters PJ, McKeon A, Leite MI, Rajasekharan S, Lennon VA, Villalobos A, Palace J, Mandrekar JN, Vincent A, Bar-Or A, Pittock SJ: Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology 2012, 78(9):665\u2013671. discussion 669. doi:10.1212\/WNL.0b013e318248dec1 10.1212\/WNL.0b013e318248dec1","journal-title":"Neurology"},{"issue":"4","key":"107_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005, 202(4):473\u2013477. doi:10.1084\/jem.20050304 10.1084\/jem.20050304","journal-title":"J Exp Med"},{"issue":"4","key":"107_CR3","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrn3468","volume":"14","author":"MC Papadopoulos","year":"2013","unstructured":"Papadopoulos MC, Verkman AS: Aquaporin water channels in the nervous system. Nat Rev Neurosci 2013, 14(4):265\u2013277. doi:10.1038\/nrn3468 10.1038\/nrn3468","journal-title":"Nat Rev Neurosci"},{"issue":"24","key":"107_CR4","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1212\/01.WNL.0000289761.64862.ce","volume":"69","author":"SR Hinson","year":"2007","unstructured":"Hinson SR, Pittock SJ, Lucchinetti CF, Roemer SF, Fryer JP, Kryzer TJ, Lennon VA: Pathogenic potential of IgG binding to water channel extracellular domain in neuromyelitis optica. Neurology 2007, 69(24):2221\u20132231. doi:10.1212\/01.WNL.0000289761.64862.ce 10.1212\/01.WNL.0000289761.64862.ce","journal-title":"Neurology"},{"issue":"Pt 2","key":"107_CR5","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC: Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain 2010, 133(Pt 2):349\u2013361.","journal-title":"Brain"},{"issue":"6","key":"107_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS: Aquaporin 4 and neuromyelitis optica. Lancet Neurol 2012, 11(6):535\u2013544. doi:10.1016\/S1474\u20134422(12)70133\u20133 10.1016\/S1474-4422(12)70133-3","journal-title":"Lancet Neurol"},{"issue":"23","key":"107_CR7","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1212\/01.wnl.0000303817.82134.da","volume":"70","author":"M Matiello","year":"2008","unstructured":"Matiello M, Lennon VA, Jacob A, Pittock SJ, Lucchinetti CF, Wingerchuk DM, Weinshenker BG: NMO-IgG predicts the outcome of recurrent optic neuritis. Neurology 2008, 70(23):2197\u20132200. 10.1212\/01.wnl.0000303817.82134.da","journal-title":"Neurology"},{"issue":"1","key":"107_CR8","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/1742-2094-9-14","volume":"9","author":"S Jarius","year":"2012","unstructured":"Jarius S, Ruprecht K, Wildemann B, Kuempfel T, Ringelstein M, Geis C, Kleiter I, Kleinschnitz C, Berthele A, Brettschneider J, Hellwig K, Hemmer B, Linker RA, Lauda F, Mayer CA, Tumani H, Melms A, Trebst C, Stangel M, Marziniak M, Hoffmann F, Schippling S, Faiss JH, Neuhaus O, Ettrich B, Zentner C, Guthke K, Hofstadt-van Oy U, Reuss R, Pellkofer H, et al.: Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients. J Neuroinflammation 2012, 9(1):14. doi:10.1186\/1742\u20132094\u20139-14 10.1186\/1742-2094-9-14","journal-title":"J Neuroinflammation"},{"issue":"3","key":"107_CR9","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s00415-010-5780-4","volume":"258","author":"G Akman-Demir","year":"2011","unstructured":"Akman-Demir G, Tuzun E, Waters P, Icoz S, Kurtuncu M, Jarius S, Yapici Z, Mutlu M, Yesilot N, Vincent A, Eraksoy M: Prognostic implications of aquaporin-4 antibody status in neuromyelitis optica patients. J Neurol 2011, 258(3):464\u2013470. doi:10.1007\/s00415\u2013010\u20135780\u20134 10.1007\/s00415-010-5780-4","journal-title":"J Neurol"},{"key":"107_CR10","volume-title":"JAMA Neurol","author":"J Kitley","year":"2013","unstructured":"Kitley J, Leite MI, Kuker W, Quaghebeur G, George J, Waters P, Woodhall M, Vincent A, Palace J: Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol 2013. EPub ahead of print. doi:10.1001\/jamaneurol.2013.3890"},{"issue":"12","key":"107_CR11","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1212\/WNL.0b013e31826aac4e","volume":"79","author":"J Kitley","year":"2012","unstructured":"Kitley J, Woodhall M, Waters P, Leite MI, Devenney E, Craig J, Palace J, Vincent A: Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype. Neurology 2012, 79(12):1273\u20131277. doi:10.1212\/WNL.0b013e31826aac4e 10.1212\/WNL.0b013e31826aac4e","journal-title":"Neurology"},{"key":"107_CR12","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/1742-2094-8-184","volume":"8","author":"S Mader","year":"2011","unstructured":"Mader S, Gredler V, Schanda K, Rostasy K, Dujmovic I, Pfaller K, Lutterotti A, Jarius S, Di Pauli F, Kuenz B, Ehling R, Hegen H, Deisenhammer F, Aboul-Enein F, Storch MK, Koson P, Drulovic J, Kristoferitsch W, Berger T, Reindl M: Complement activating antibodies to myelin oligodendrocyte glycoprotein in neuromyelitis optica and related disorders. J Neuroinflammation 2011, 8: 184. doi:10.1186\/1742\u20132094\u20138-184 10.1186\/1742-2094-8-184","journal-title":"J Neuroinflammation"},{"issue":"8","key":"107_CR13","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1177\/1352458512470310","volume":"19","author":"K Rostasy","year":"2013","unstructured":"Rostasy K, Mader S, Hennes EM, Schanda K, Gredler V, Guenther A, Blaschek A, Korenke C, Pritsch M, Pohl D, Maier O, Kuchukhidze G, Brunner-Krainz M, Berger T, Reindl M: Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Mult Scler 2013, 19(8):1052\u20131059. doi:10.1177\/1352458512470310 10.1177\/1352458512470310","journal-title":"Mult Scler"},{"issue":"2","key":"107_CR14","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.brainresrev.2004.01.003","volume":"45","author":"P Vourc\u2019h","year":"2004","unstructured":"Vourc\u2019h P, Andres C: Oligodendrocyte myelin glycoprotein (OMgp): evolution, structure and function. Brain Res Brain Res Rev 2004, 45(2):115\u2013124. doi:10.1016\/j.brainresrev.2004.01.003 10.1016\/j.brainresrev.2004.01.003","journal-title":"Brain Res Brain Res Rev"},{"key":"107_CR15","volume-title":"JAMA Neurol","author":"J Kitley","year":"2014","unstructured":"Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, Kuker W, Chandratre S, Vincent A, Palace J: Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol 2014. doi:10.1001\/jamaneurol.2013.5857"},{"key":"107_CR16","volume-title":"Neurology","author":"DK Sato","year":"2014","unstructured":"Sato DK, Callegaro D, Lana-Peixoto MA, Waters PJ, de Haidar Jorge FM, Takahashi T, Nakashima I, Apostolos-Pereira SL, Talim N, Simm RF, Martins Lino AM, Misu T, Leite MI, Aoki M, Fujihara K: Distinction between MOG antibody-positive and AQP4 antibody-positive NMO spectrum disorders. Neurology 2014. doi:10.1212\/WNL.0000000000000101"},{"issue":"3","key":"107_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1002\/ana.22686","volume":"71","author":"S Saadoun","year":"2012","unstructured":"Saadoun S, Waters P, MacDonald C, Bell BA, Vincent A, Verkman AS, Papadopoulos MC: Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain. Ann Neurol 2012, 71(3):323\u2013333. doi:10.1002\/ana.22686 10.1002\/ana.22686","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"107_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jneuroim.2011.03.007","volume":"235","author":"S Saadoun","year":"2011","unstructured":"Saadoun S, Waters P, Macdonald C, Bridges LR, Bell BA, Vincent A, Verkman AS, Papadopoulos MC: T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement. J Neuroimmunol 2011, 235(1\u20132):27\u201332. doi:10.1016\/j.jneuroim.2011.03.007","journal-title":"J Neuroimmunol"},{"issue":"6","key":"107_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/ana.21641","volume":"65","author":"GP Owens","year":"2009","unstructured":"Owens GP, Bennett JL, Lassmann H, O\u2019Connor KC, Ritchie AM, Shearer A, Lam C, Yu X, Birlea M, DuPree C, Williamson RA, Hafler DA, Burgoon MP, Gilden D: Antibodies produced by clonally expanded plasma cells in multiple sclerosis cerebrospinal fluid. Ann Neurol 2009, 65(6):639\u2013649. doi:10.1002\/ana.21641 10.1002\/ana.21641","journal-title":"Ann Neurol"},{"issue":"5","key":"107_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/ana.21802","volume":"66","author":"JL Bennett","year":"2009","unstructured":"Bennett JL, Lam C, Kalluri SR, Saikali P, Bautista K, Dupree C, Glogowska M, Case D, Antel JP, Owens GP, Gilden D, Nessler S, Stadelmann C, Hemmer B: Intrathecal pathogenic anti-aquaporin-4 antibodies in early neuromyelitis optica. Ann Neurol 2009, 66(5):617\u2013629. doi: 10.1002\/ana.21802 10.1002\/ana.21802","journal-title":"Ann Neurol"},{"issue":"5","key":"107_CR21","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1083\/jcb.143.5.1295","volume":"143","author":"D Zhou","year":"1998","unstructured":"Zhou D, Lambert S, Malen PL, Carpenter S, Boland LM, Bennett V: AnkyrinG is required for clustering of voltage-gated Na channels at axon initial segments and for normal action potential firing. J Cell Biol 1998, 143(5):1295\u20131304. 10.1083\/jcb.143.5.1295","journal-title":"J Cell Biol"},{"issue":"2","key":"107_CR22","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/S0896-6273(01)00294-X","volume":"30","author":"MA Bhat","year":"2001","unstructured":"Bhat MA, Rios JC, Lu Y, Garcia-Fresco GP, Ching W, St Martin M, Li J, Einheber S, Chesler M, Rosenbluth J, Salzer JL, Bellen HJ: Axon-glia interactions and the domain organization of myelinated axons requires neurexin IV\/Caspr\/Paranodin. Neuron 2001, 30(2):369\u2013383. 10.1016\/S0896-6273(01)00294-X","journal-title":"Neuron"},{"issue":"7","key":"107_CR23","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.4049\/jimmunol.1301296","volume":"191","author":"MC Mayer","year":"2013","unstructured":"Mayer MC, Breithaupt C, Reindl M, Schanda K, Rostasy K, Berger T, Dale RC, Brilot F, Olsson T, Jenne D, Probstel AK, Dornmair K, Wekerle H, Hohlfeld R, Banwell B, Bar-Or A, Meinl E: Distinction and temporal stability of conformational epitopes on myelin oligodendrocyte glycoprotein recognized by patients with different inflammatory central nervous system diseases. J Immunol 2013, 191(7):3594\u20133604. doi:10.4049\/jimmunol.1301296 10.4049\/jimmunol.1301296","journal-title":"J Immunol"},{"issue":"39","key":"107_CR24","doi-asserted-by":"publisher","first-page":"13992","DOI":"10.1073\/pnas.0504979102","volume":"102","author":"CB Marta","year":"2005","unstructured":"Marta CB, Oliver AR, Sweet RA, Pfeiffer SE, Ruddle NH: Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology. Proc Natl Acad Sci U S A 2005, 102(39):13992\u201313997. doi:10.1073\/pnas.0504979102 10.1073\/pnas.0504979102","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"13","key":"107_CR25","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1523\/JNEUROSCI.23-13-05461.2003","volume":"23","author":"CB Marta","year":"2003","unstructured":"Marta CB, Taylor CM, Coetzee T, Kim T, Winkler S, Bansal R, Pfeiffer SE: Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci 2003, 23(13):5461\u20135471.","journal-title":"J Neurosci"},{"issue":"5","key":"107_CR26","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1517\/14728222.2012.677438","volume":"16","author":"DH Lee","year":"2012","unstructured":"Lee DH, Linker RA: The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy? Expert Opin Ther Targets 2012, 16(5):451\u2013462. doi: 10.1517\/14728222.2012.677438 10.1517\/14728222.2012.677438","journal-title":"Expert Opin Ther Targets"},{"issue":"50","key":"107_CR27","doi-asserted-by":"publisher","first-page":"19057","DOI":"10.1073\/pnas.0607242103","volume":"103","author":"D Zhou","year":"2006","unstructured":"Zhou D, Srivastava R, Nessler S, Grummel V, Sommer N, Bruck W, Hartung HP, Stadelmann C, Hemmer B: Identification of a pathogenic antibody response to native myelin oligodendrocyte glycoprotein in multiple sclerosis. Proc Natl Acad Sci U S A 2006, 103(50):19057\u201319062. doi:10.1073\/pnas.0607242103 10.1073\/pnas.0607242103","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"107_CR28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/oxfordjournals.jhered.a109442","volume":"72","author":"GF Chernoff","year":"1981","unstructured":"Chernoff GF: Shiverer: an autosomal recessive mutant mouse with myelin deficiency. J Hered 1981, 72(2):128.","journal-title":"J Hered"},{"issue":"8","key":"107_CR29","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrneurol.2013.118","volume":"9","author":"M Reindl","year":"2013","unstructured":"Reindl M, Di Pauli F, Rostasy K, Berger T: The spectrum of MOG autoantibody-associated demyelinating diseases. Nat Rev Neurol 2013, 9(8):455\u2013461. doi: 10.1038\/nrneurol.2013.118 10.1038\/nrneurol.2013.118","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"107_CR30","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/S1474-4422(13)70076-0","volume":"12","author":"SJ Pittock","year":"2013","unstructured":"Pittock SJ, Lennon VA, McKeon A, Mandrekar J, Weinshenker BG, Lucchinetti CF, O\u2019Toole O, Wingerchuk DM: Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol 2013, 12(6):554\u2013562. doi:10.1016\/S1474\u20134422(13)70076\u20130 10.1016\/S1474-4422(13)70076-0","journal-title":"Lancet Neurol"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/2051-5960-2-35\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-35","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/2051-5960-2-35.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T03:13:21Z","timestamp":1630552401000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/2051-5960-2-35"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,31]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["107"],"URL":"https:\/\/doi.org\/10.1186\/2051-5960-2-35","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,31]]},"assertion":[{"value":"9 March 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"35"}}